New York-based Pfizer Inc. shares slipped 0.07% to $41.02 Wednesday. This proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.82% to 4,358.69 and the Dow Jones Industrial Average DJIA rising 0.83% to 34,798.00.
Pfizer Inc. closed $2.06 short of its 52-week high ($43.08), which the company reached on December 9th. The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ rose 0.62% to $169.49, Merck & Co. Inc. MRK rose 0.29% to $76.39, and Novartis AG ADR NVS rose 0.27% to $90.48.
Wall Street will be looking for positivity from PFE as it approaches its next earnings report date. This is expected to be July 28, 2021. In that report, analysts expect PFE to post earnings of $0.96 per share. This would mark year-over-year growth of 23.08%. Meanwhile, our latest consensus estimate is calling for revenue of $17.54 billion, up 48.61% from the prior year quarter.